INTS
NASDAQ · Biotechnology
Intensity Therapeutics Inc
$3.65
-0.15 (-3.95%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+913.7% upside
Low Target
$31.85
Average Target
$37.00
High Target
$43.82
Current Price
$3.65
Current
$3.65
$3.65
Target
$37.00
$37.00
$31.85
$37.00 avg
$43.82
Scenario Analysis
Bear Case
$31.85
772.6%
Low target
Base Case
$37.00
+913.7%
Avg target
Bull Case
$43.82
+1,100.5%
High target
Risk/Reward
1.4x
Balanced
Price in Context
52-Week High
$43.50
-91.6% from high
52-Week Low
$3.51
+4.0% from low
Target vs 52W High
$37.00
-14.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |